Expression data from human endometrial cancer cell line AN3-CA treated with 300 nM AZD4547

ABSTRACT: AZD4547,pan-FGFR inhibitor, have been reported to have profound therapeutic effects on FGFR-deregulated cancers. AN3-CA is one of endometrial cancer cell lines harbouring FGFR2 mutants. AZD4547 showed a potent antiprolierative effect on AN3-CA cells. we used microarray to investigate transcriptome-wide change in gene expression followinig 300 nM AZD4547 treatment to explain the chemotherapeutic effect.

ORGANISM(S): Homo sapiens

PROVIDER: GSE61481 | GEO | 2015/09/17

SECONDARY ACCESSION(S): PRJNA261280

REPOSITORIES: GEO